22nw, LP
13F holdings for Q2 2026 · SEATTLE, WA · filed August 14, 2026
22nw, LP reported $105M in 13F securities across 14 holdings for Q2 2026, in a Form 13F filed August 14, 2026. The largest positions were NSP (19.5%), NKTR (18.7%), SRI (17.3%). Reported value fell 17.6% from the quarter before. It opened 1 new position, added to 1, trimmed 1 and sold out of 3.
- 13F value Q2 2026
- $105M
- Holdings
- 14
- Change vs prior quarter
- -17.6%
- Rank by 13F value
- #8,237
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| NSP Insperity Inc. | $20.4M | 19.5% | 493,000 | 0% | Unchanged |
| NKTR Nektar Therapeutics | $19.6M | 18.7% | 281,115 | 0% | Unchanged |
| SRI Stoneridge Inc. | $18.1M | 17.3% | 2,466,975 | 0% | Unchanged |
| FOXF Fox Factory Holding Corp. | $11.5M | 11.0% | 678,165 | 0% | Unchanged |
| CMT Core Molding Technologies Inc | $6.5M | 6.2% | 273,521 | +22.8% | Added |
| RGNX REGENXBIO Inc. | $5.9M | 5.6% | 492,759 | 0% | Unchanged |
| CULP Culp Inc. | $5.8M | 5.5% | 1,859,061 | 0% | Unchanged |
| RZLT Rezolute Inc. | $4.3M | 4.1% | 820,653 | 0% | Unchanged |
| UFI Unifi Inc. New | $4.0M | 3.9% | 852,455 | 0% | Unchanged |
| MLYS Mineralys Therapeutics Inc. | $3.1M | 2.9% | 113,840 | -74.4% | Trimmed |
| TISI Team Inc. | $2.9M | 2.8% | 170,187 | 0% | Unchanged |
| ELDN Eledon Pharmaceuticals Inc. | $2.5M | 2.4% | 636,364 | 0% | Unchanged |
| TBCH Turtle Beach Corporation | $180K | 0.2% | 14,430 | New | New |
| LFCR Lifecore Biomedical Inc. | $6K | 0.0% | 1,254 | 0% | Unchanged |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $105M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
- CMT Core Molding Technologies Inc Added+$1.2M
- TBCH Turtle Beach Corporation New+$180K
Biggest sells in Q2 2026
- FSTR L.B. Foster Company Sold out-$29.8M
- MLYS Mineralys Therapeutics Inc. Trimmed-$8.9M
- Farmer Bros Co Sold out-$2.5M
- PFX PhenixFIN Corporation Sold out-$1.7M
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 1 new, 1 added, 1 trimmed, 3 sold out.
Sector mix
- Consumer Discretionary59.9%
- Health Care33.8%
- Industrials6.2%
- Telecommunications0.2%
13F value by quarter
Questions about 22nw, LP
- What does 22nw, LP own?
- In its Form 13F for Q2 2026, 22nw, LP reported 14 holdings worth $105M. The five largest were NSP, NKTR, SRI, FOXF, CMT.
- What did 22nw, LP buy and sell in Q2 2026?
- 22nw, LP opened 1 new position, added to 1, trimmed 1 and sold out of 3 compared with the quarter before.
- When did 22nw, LP file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 14, 2026.
From Form 13F filed by 22nw, LP (SEC CIK 0001694297) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds